Disease ID | Disease name | Source of annotation with MTOR | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
616638 | SMITH-KINGSMORE SYNDROME | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | MTOR |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Type II diabetes mellitus | hsa04930 | 7.12 |
Proteoglycans in cancer | hsa05205 | 5.02 |
Adipocytokine signaling pathway | hsa04920 | 6.6 |
MicroRNAs in cancer | hsa05206 | 5.38 |
Pathways in cancer | hsa05200 | 3.98 |
Glioma | hsa05214 | 6.66 |
Prostate cancer | hsa05215 | 6.11 |
ErbB signaling pathway | hsa04012 | 6.15 |
Insulin signaling pathway | hsa04910 | 5.55 |
Central carbon metabolism in cancer | hsa05230 | 6.7 |
Choline metabolism in cancer | hsa05231 | 6.09 |
Acute myeloid leukemia | hsa05221 | 6.74 |
HIF-1 signaling pathway | hsa04066 | 5.9 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 |
AMPK signaling pathway | hsa04152 | 5.8 |
mTOR signaling pathway | hsa04150 | 6.72 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.73 |
PI3K/AKT activation | R-HSA-198203 | 6.32 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
PI3K Cascade | R-HSA-109704 | 6.68 |
Immune System | R-HSA-168256 | 2.37 |
PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
GAB1 signalosome | R-HSA-180292 | 6.31 |
IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Disease | R-HSA-1643685 | 3.33 |
Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
Gene Expression | R-HSA-74160 | 2.72 |
PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
Cellular responses to stress | R-HSA-2262752 | 4.56 |
IRS-mediated signalling | R-HSA-112399 | 4.87 |
Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.4 |
CD28 co-stimulation | R-HSA-389356 | 7.98 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
Costimulation by the CD28 family | R-HSA-388841 | 6.56 |
Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.18 |
PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.59 |
Innate Immune System | R-HSA-168249 | 3.17 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
HSF1-dependent transactivation | R-HSA-3371571 | 8.59 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
Signaling by VEGF | R-HSA-194138 | 4.66 |
PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
Macroautophagy | R-HSA-1632852 | 6.92 |
Signalling by NGF | R-HSA-166520 | 4.23 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
mTOR signalling | R-HSA-165159 | 7.7 |
Generic Transcription Pathway | R-HSA-212436 | 3.86 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
PKB-mediated events | R-HSA-109703 | 7.66 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.28 |
mTORC1-mediated signalling | R-HSA-166208 | 8.52 |
TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.73 |
Signal Transduction | R-HSA-162582 | 1.78 |
Cellular response to heat stress | R-HSA-3371556 | 6.59 |
GO term | GO ID | GO IC |
---|---|---|
RNA polymerase III type 1 promoter DNA binding | GO:0001030 | 8.64 |
RNA polymerase III type 2 promoter DNA binding | GO:0001031 | 8.64 |
RNA polymerase III type 3 promoter DNA binding | GO:0001032 | 8.64 |
rDNA binding | GO:0000182 | 7.66 |
TFIIIC-class transcription factor binding | GO:0001156 | 9.05 |
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
RNA polymerase III regulatory region DNA binding | GO:0001016 | 8.35 |
5S rDNA binding | GO:0080084 | 8.64 |
enzyme binding | GO:0019899 | 2.27 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
nucleic acid binding | GO:0003676 | 1.44 |
DNA binding | GO:0003677 | 1.92 |
heterocyclic compound binding | GO:1901363 | 1.06 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
nucleoside binding | GO:0001882 | 2.21 |
sequence-specific DNA binding | GO:0043565 | 2.79 |
sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
kinase binding | GO:0019900 | 3.32 |
nucleotide binding | GO:0000166 | 1.96 |
protein serine/threonine kinase activity | GO:0004674 | 3.64 |
transferase activity | GO:0016740 | 1.95 |
purine nucleoside binding | GO:0001883 | 2.22 |
protein kinase activity | GO:0004672 | 3.27 |
ribonucleoprotein complex binding | GO:0043021 | 5.15 |
purine nucleotide binding | GO:0017076 | 2.19 |
double-stranded DNA binding | GO:0003690 | 3.09 |
ribosome binding | GO:0043022 | 5.83 |
ATP binding | GO:0005524 | 2.43 |
regulatory region DNA binding | GO:0000975 | 3.03 |
RNA polymerase III transcription factor binding | GO:0001025 | 8.35 |
kinase activity | GO:0016301 | 2.93 |
transcription regulatory region DNA binding | GO:0044212 | 3.03 |
transcription factor binding | GO:0008134 | 3.46 |
ribonucleoside binding | GO:0032549 | 2.22 |
regulatory region nucleic acid binding | GO:0001067 | 3.03 |
protein kinase binding | GO:0019901 | 3.44 |
catalytic activity | GO:0003824 | 1.05 |
protein domain specific binding | GO:0019904 | 3.32 |
small molecule binding | GO:0036094 | 1.89 |
adenyl nucleotide binding | GO:0030554 | 2.4 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
organic cyclic compound binding | GO:0097159 | 1.05 |
phosphoprotein binding | GO:0051219 | 5.64 |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
adenyl ribonucleotide binding | GO:0032559 | 2.41 |
protein binding | GO:0005515 | 0.46 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |